| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.76B | 11.02B | 9.43B | 12.31B | 12.01B | 7.32B |
| Gross Profit | 7.39B | 6.77B | 5.38B | 7.88B | 7.80B | 4.86B |
| EBITDA | 5.52B | 5.03B | 4.20B | 6.17B | 5.60B | 2.59B |
| Net Income | 2.71B | 2.27B | 1.64B | 3.31B | 2.75B | 1.39B |
Balance Sheet | ||||||
| Total Assets | 47.99B | 47.99B | 48.23B | 48.79B | 50.30B | 52.32B |
| Cash, Cash Equivalents and Short-Term Investments | 4.05B | 3.65B | 2.36B | 958.06M | 1.47B | 1.98B |
| Total Debt | 8.68B | 8.66B | 7.65B | 7.01B | 6.60B | 6.82B |
| Total Liabilities | 14.20B | 14.18B | 13.05B | 13.23B | 13.84B | 14.33B |
| Stockholders Equity | 33.79B | 33.82B | 35.18B | 35.57B | 36.47B | 37.99B |
Cash Flow | ||||||
| Free Cash Flow | 4.56B | 4.28B | 3.12B | 3.56B | 3.78B | 2.39B |
| Operating Cash Flow | 5.05B | 4.81B | 3.85B | 4.82B | 4.48B | 2.74B |
| Investing Cash Flow | -1.23B | -1.32B | -1.10B | -1.27B | -657.37M | 2.14B |
| Financing Cash Flow | -3.26B | -2.98B | -1.71B | -4.06B | -4.29B | -3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $196.39B | 45.73 | 7.92% | 1.43% | 25.91% | 74.58% | |
77 Outperform | $74.12B | 10.55 | 26.14% | 1.79% | 2.37% | 13.28% | |
74 Outperform | $255.81B | 28.56 | 32.49% | 3.11% | 14.89% | 10.49% | |
72 Outperform | $313.07B | 31.26 | 38.90% | 0.69% | 2.15% | 27.46% | |
71 Outperform | $189.28B | 15.44 | 40.19% | 2.01% | 5.21% | -6.72% | |
68 Neutral | $144.42B | 42.24 | 19.38% | 0.28% | 42.09% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |